» Articles » PMID: 24189291

The Nature and Evolution of Insight in Schizophrenia: a Multi-informant Longitudinal Study of First-episode Versus Chronic Patients

Overview
Journal Schizophr Res
Specialty Psychiatry
Date 2013 Nov 6
PMID 24189291
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: This study investigated a novel distinction between two possible sources of poor insight in schizophrenia: primary unawareness, in which the ill person is not aware that other people think one has a problem, and secondary unawareness (or disagreement), in which a person does appreciate that other people think one has a problem. A secondary goal was to compare the evolution of insight in first-episode and chronic schizophrenia.

Methods: Sixty-eight first-episode and 51 chronic patients were administered two versions of the Scale of Unawareness of Mental Disorder (SUMD) at three time points: hospital admission, discharge, and 6-month post-discharge. In the first standard SUMD version, they were asked about their own opinions, whereas in the second modified version, they were asked about their best guess of their doctor's opinion.

Results: While overall level of unawareness remained stable within each single episode, there were significant Type of Unawareness (primary versus secondary) by Clinical Status (admission versus discharge versus 6-month post-discharge) and Type of Unawareness by Phase of Illness (first-episode versus chronic) interaction effects. More specifically, in the first-episode group, primary unawareness steadily decreased over time. In contrast, in the chronic group, primary unawareness decreased markedly during hospitalization and returned to baseline after discharge.

Conclusions: These results provide preliminary support for the notion that impaired insight is an additive outcome of primary unawareness and disagreement, and that change in insight over time occurs mostly at the level of their relative proportion as opposed to their overall sum. Implications for studying and treating poor insight in schizophrenia are discussed.

Citing Articles

Impaired insight in schizophrenia is associated with higher frontoparietal cerebral blood flow: an arterial spin labeling study.

Song J, Carmona-Torres E, Kambari Y, Chavez S, Ueno F, Koizum T Schizophrenia (Heidelb). 2025; 11(1):2.

PMID: 39794339 PMC: 11723987. DOI: 10.1038/s41537-024-00536-3.


Role of Clinical Insight at First Month in Predicting Relapse at the Year in First Episode of Psychosis (FEP) Patients.

Vlachos I, Selakovic M, Ralli I, Hatzimanolis A, Xenaki L, Dimitrakopoulos S J Clin Med. 2023; 12(13).

PMID: 37445295 PMC: 10342885. DOI: 10.3390/jcm12134261.


Clinical insight among persons with schizophrenia spectrum disorders treated with amisulpride, aripiprazole or olanzapine: a semi-randomised trial.

Stabell L, Johnsen E, Kroken R, Loberg E, Blindheim A, Joa I BMC Psychiatry. 2023; 23(1):482.

PMID: 37386462 PMC: 10311854. DOI: 10.1186/s12888-023-04981-9.


A Randomized Controlled Trial of the Effects of Early Intervention Services On Insight in First Episode Psychosis.

DeTore N, Bain K, Wright A, Meyer-Kalos P, Gingerich S, Mueser K Schizophr Bull. 2022; 48(6):1295-1305.

PMID: 35997816 PMC: 9673270. DOI: 10.1093/schbul/sbac099.


Accuracy of self-assessment of real-life functioning in schizophrenia.

Rocca P, Brasso C, Montemagni C, Bellino S, Rossi A, Bertolino A NPJ Schizophr. 2021; 7(1):11.

PMID: 33589645 PMC: 7884703. DOI: 10.1038/s41537-021-00140-9.